Melanoma genetics: An update with focus on the CDKN2A(p16)/ARF tumor suppressors
- 1 May 2000
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 42 (5) , 705-726
- https://doi.org/10.1067/mjd.2000.104687
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- Stability and folding of the tumour suppressor protein p16Journal of Molecular Biology, 1999
- CDKN2a/p16INK4a Mutations and Lack of p19ARF Involvement in Familial Melanoma KindredsJournal of Investigative Dermatology, 1998
- Genetic Alterations ofp16INK4aandp53Genes in Sporadic Dysplastic NevusBiochemical and Biophysical Research Communications, 1997
- A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor GeneNew England Journal of Medicine, 1995
- Molecular Cloning, Expression Pattern, and Chromosomal Localization of Human CDKN2D/INK4d,an Inhibitor of Cyclin D-Dependent KinasesGenomics, 1995
- Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibitionNature, 1995
- Genetic basis of susceptibility to melanomaJournal of the American Academy of Dermatology, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Locus for Susceptibility to Melanoma on Chromosome 1pNew England Journal of Medicine, 1990
- Mapping the Gene for Hereditary Cutaneous Malignant Melanoma–Dysplastic Nevus to Chromosome LpNew England Journal of Medicine, 1989